Shares of MaxLinear, Inc. (NASDAQ:MXL - Get Free Report) have been given a consensus recommendation of "Hold" by the nine ratings firms that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $19.06.
MXL has been the topic of a number of recent analyst reports. Loop Capital reduced their price target on shares of MaxLinear from $18.00 to $10.00 and set a "hold" rating on the stock in a research report on Tuesday, April 29th. Roth Capital set a $11.00 target price on shares of MaxLinear and gave the stock a "neutral" rating in a report on Thursday, April 24th. Benchmark reaffirmed a "buy" rating and set a $20.00 price target on shares of MaxLinear in a research report on Thursday, April 24th. Finally, Stifel Nicolaus dropped their price objective on shares of MaxLinear from $26.00 to $16.00 and set a "buy" rating on the stock in a report on Thursday, April 17th.
Get Our Latest Stock Report on MXL
Insiders Place Their Bets
In other MaxLinear news, Director Ted L. Tewksbury III sold 6,071 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $10.40, for a total transaction of $63,138.40. Following the transaction, the director now owns 74,995 shares of the company's stock, valued at $779,948. The trade was a 7.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.80% of the company's stock.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company grew its position in shares of MaxLinear by 48.2% in the first quarter. The Manufacturers Life Insurance Company now owns 2,260,392 shares of the semiconductor company's stock valued at $24,548,000 after purchasing an additional 734,973 shares during the last quarter. Invesco Ltd. boosted its stake in MaxLinear by 414.8% in the first quarter. Invesco Ltd. now owns 1,684,247 shares of the semiconductor company's stock valued at $18,291,000 after buying an additional 1,357,093 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in MaxLinear by 3,698.1% in the fourth quarter. The Manufacturers Life Insurance Company now owns 1,525,419 shares of the semiconductor company's stock valued at $30,173,000 after buying an additional 1,485,256 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of MaxLinear during the 4th quarter valued at $25,659,000. Finally, Vaughan Nelson Investment Management L.P. boosted its stake in shares of MaxLinear by 10.0% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,268,857 shares of the semiconductor company's stock valued at $25,098,000 after purchasing an additional 115,867 shares in the last quarter. 90.79% of the stock is owned by institutional investors and hedge funds.
MaxLinear Stock Performance
NASDAQ MXL traded down $0.09 during midday trading on Monday, hitting $12.11. The company had a trading volume of 982,314 shares, compared to its average volume of 1,470,184. MaxLinear has a fifty-two week low of $8.35 and a fifty-two week high of $26.59. The stock has a market cap of $1.02 billion, a price-to-earnings ratio of -4.13 and a beta of 1.66. The firm has a fifty day simple moving average of $10.98 and a two-hundred day simple moving average of $15.15. The company has a quick ratio of 1.28, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.
MaxLinear (NASDAQ:MXL - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The semiconductor company reported ($0.05) earnings per share for the quarter, meeting the consensus estimate of ($0.05). The business had revenue of $95.93 million for the quarter, compared to analyst estimates of $95.32 million. MaxLinear had a negative net margin of 68.01% and a negative return on equity of 21.94%. The firm's revenue was up .7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.21) EPS. Equities analysts forecast that MaxLinear will post -0.37 earnings per share for the current fiscal year.
About MaxLinear
(
Get Free ReportMaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Featured Articles

Before you consider MaxLinear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.
While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.